| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $2,900,814 ) |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY032762 | Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | 000 | 3 | NIH | 1/30/2024 | $600,249 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | U01NS119560 | Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment | 000 | 2 | NIH | 2/13/2024 | $737,787 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY034111 | Mechanisms of immunological memory-mediated pathogenesis in chronic autoimmune uveitis | 000 | 2 | NIH | 4/18/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | U01NS119560 | Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment | 001 | 2 | NIH | 4/10/2024 | $60,462 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY033211 | Regulating cell-cell interactions to improve donor retinal ganglion cell integration | 000 | 3 | NIH | 1/26/2024 | $74,492 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY024602 | Ocular Immune Regulation by Mesenchymal Stem Cells | 000 | 10 | NIH | 3/13/2024 | $492,500 |
| | 2024 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020889 | Immunopathogenic mechanisms of dry eye disease | 000 | 14 | NIH | 11/29/2023 | $492,500 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035947 | VRC Inhibiting p38 to Prevent and Restore Corneal Scarring | 000 | 1 | NIH | 2/28/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY035298 | Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma | 000 | 1 | NIH | 12/1/2023 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031777 | Monocular Visual Confusion for Field Expansion | 000 | 4 | NIH | 2/1/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 001 | 5 | NIH | 3/1/2024 | $157,832 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY023385 | Visual Field Expansion Through Innovative Multi-periscopic Prism Design | 000 | 10 | NIH | 2/15/2024 | $0 |
| | 2024 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | P30EY003790 | Core Grant for Vision Research | 000 | 42 | NIH | 4/5/2024 | $0 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY031373 | Mesenchymal Stem Cells can Restore and Maintain Corneal Endothelial Function | 000 | 2 | NIH | 10/19/2023 | $0 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY032695 | Therapeutic Function of alpha-Melanocyte Stimulating Hormone (?-MSH) in Acute Injury and Chronic Degeneration of Corneal Endothelium | 000 | 2 | NIH | 2/12/2024 | -$743 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY031781 | Pathogenicity of memory Th17 cells in chronic autoimmune uveitis | 000 | 2 | NIH | 4/11/2024 | $0 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY030553 | Generation of suturable artificial cornea from the integration of exfoliated graphene with gelatin glycidyl methacrylate | 000 | 2 | NIH | 2/12/2024 | -$619 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 000 | 4 | NIH | 3/1/2024 | -$157,832 |
| | 2024 | 2022 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029268 | Protective function of STAT3-mediated astrocyte reactivity in experimental glaucoma: mechanism of action | 000 | 5 | NIH | 2/26/2024 | -$47,050 |
| | 2024 | 2021 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R13EY032405 | The 7th Military Vision Symposium on Ocular Readiness for Military Conflicts and Civilian Casualties | 000 | 1 | NIH | 4/9/2024 | -$1,264 |
| | 2024 | 2019 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | RF1NS110048 | Charting vascular contributions to white matter disease in familial Alzheimer's disease and CADASIL | 000 | 1 | NIH | 3/26/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $15,765,010 ) (Continued on the next page) |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY019470 | Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution | 001 | 14 | NIH | 2/13/2023 | $0 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031696 | Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | 000 | 3 | NIH | 8/24/2023 | $717,827 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R00EY028631 | Relationship between Glaucoma and the Three-Dimensional Optic Nerve Head Related Structure | 000 | 5 | NIH | 1/27/2023 | $247,154 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 000 | 5 | NIH | 5/1/2023 | $492,500 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY033487 | The astrocyte transcriptome in age and glaucoma: a comparative study of the optic nerve head, optic nerve proper and corpus callosum | 000 | 2 | NIH | 8/2/2023 | $246,250 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY034345 | Overcome the barriers of vision care in Africa using smartphones | 001 | 2 | NIH | 6/8/2023 | $1,000 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY034345 | Overcome the barriers of vision care in Africa using smartphones | 001 | 2 | NIH | 6/8/2023 | $244,074 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020581 | Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy | 000 | 14 | NIH | 7/12/2023 | $410,000 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY033211 | Regulating cell-cell interactions to improve donor retinal ganglion cell integration | 000 | 2 | NIH | 2/16/2023 | $72,200 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY032762 | Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | 001 | 2 | NIH | 8/23/2023 | $43,575 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY032762 | Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | 000 | 2 | NIH | 1/27/2023 | $600,249 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035312 | Mechanisms of microglial neuroinflammatory response in glaucoma | 000 | 1 | NIH | 8/16/2023 | $492,500 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY030575 | Personalizing Glaucoma Diagnosis by Disease Specific Patterns and Individual Eye Anatomy | 000 | 5 | NIH | 7/24/2023 | $461,248 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029789 | Construction of Conjunctival Equivalents Using Molecular Deposition Techniques | 000 | 4 | NIH | 1/23/2023 | $394,000 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY025677 | Scanning and Detection at Intersections | 000 | 8 | NIH | 8/17/2023 | $782,511 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY024602 | Ocular Immune Regulation by Mesenchymal Stem Cells | 000 | 9 | NIH | 3/13/2023 | $492,500 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY023385 | Visual Field Expansion Through Innovative Multi-periscopic Prism Design | 002 | 10 | NIH | 8/17/2023 | $854,344 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY034938 | Partial epigenetic reprogramming of retinal pigment cells in age-related degeneration, dysfunction, and injury | 000 | 1 | NIH | 6/9/2023 | $114,039 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020889 | Immunopathogenic mechanisms of dry eye disease | 001 | 13 | NIH | 3/8/2023 | $49,250 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE INC | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020889 | Immunopathogenic mechanisms of dry eye disease | 000 | 13 | NIH | 11/18/2022 | $443,250 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY012963 | Mechanisms of Sensitization in High Risk Corneal Grafts | 000 | 24 | NIH | 7/24/2023 | $671,244 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | P30EY003790 | Core Grant for Vision Research | 002 | 42 | NIH | 8/30/2023 | $949,680 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY005665 | Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | 002 | 38 | NIH | 8/24/2023 | $524,717 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031777 | Monocular Visual Confusion for Field Expansion | 000 | 4 | NIH | 8/18/2023 | $443,250 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY033288 | The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival | 002 | 2 | NIH | 8/23/2023 | $492,500 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY035298 | Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma | 000 | 1 | NIH | 9/13/2023 | $556,962 |
| | 2023 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY034833 | Tissue Hypoxia and Topical Oxygen Therapy in Ocular Mustard Gas Injury | 000 | 1 | NIH | 6/12/2023 | $246,250 |
|
